TORONTO, Aug. 27 /PRNewswire-FirstCall/ – Biosign Technologies Inc. (CNSX: BIO) today announced that the Company has filed, on SEDAR, its Listing Statement following the receipt of the TSX Venture Exchange’s (the “Exchange”) conditional approval for the listing of the Company’s securities. The listi
View full post on PR Newswire: Business Technology




